About 42 million Medicaid patients do not have the guaranteed ability to participate in clinical trials.

A recent study on the risk of Alzheimer's disease or dementia following the use of ADT was disturbing to me on two levels.

As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.

Social media is a largely untapped resource for researchers to utilize for the purpose of successfully completing trials.

Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as...